Yahoo2d
FDA says many cold medicines found over-the-counter don't work
Dr. Justin Skrzynski or Corewell Health will help us sort it out. When you have a cold and go into the drug store, your ...
The FDA wants these cold medicines off the shelves. Should Canada follow?
The FDA has proposed removing phenylephrine, a common ingredient in decongestants, due to its ineffectiveness, which may ...
The Baltimore Sun2d
FDA announces common over-the-counter cough and cold medicine doesn’t work
The Food and Drug Administration announced Wednesday its intention to remove oral phenylephrine, a common ingredient in ...
FOX 2 Detroit on MSN2d
FDA says many over-the-counter cold medicines don't work
When you have a cold and go into the drug store, your over-the-counter treatment options are endless. Dr. Justin Skrzynski of ...
FDA considers ban on cold remedy ingredient
The Food and Drug Administration (FDA) recently announced it is considering banning a common ingredient in popular ...
About 100 decongestant lawsuits claiming bogus ingredient tossed
A New York federal judge on Tuesday dismissed about 100 lawsuits that claimed Procter & Gamble , Haleon and other companies ...
Where To Buy Over-the-Counter Hearing Aids
Over-the-counter hearing aids can be purchased online or in-store through a variety of retailers. Read our guide to find the best places to purchase.
WTNH Hartford on MSN17h
Hartford HealthCare: FDA considers ban on cold remedy ingredient
The Food and Drug Administration (FDA) recently announced it is considering banning a common ingredient in popular ...
These Cold and Flu Medicines Contain Phenylephrine, the Ingredient the FDA Plans to Ban
Phenylephrine is a medication that’s been used to relieve nasal congestion caused by colds, allergies, and hay fever, per the ...
FDA seeks to remove ingredient from cold medicines after data shows it does not work
The U.S. Food and Drug Administration is taking the first step to remove an ingredient in non-prescription cold medicines ...
Arcturus: LUNAR-CF For CF Presses On With 1st Half Of 2025 Interim Data
Arcturus Therapeutics expects interim results for LUNAR-CF and LUNAR-OTC in 2025. Learn why ARCT stock presents an ...